Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 50044723
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 690nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 990nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 2.25E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 1.18E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 930nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 4.95E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 8.70E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 1.31E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 730nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 5.00E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 460nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 1.25E+4nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 1.72E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 1.64E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 1.03E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataEC50: 3.45E+3nMAssay Description:Inhibition of HDAC6 in human A549 cells assessed as tubulin acetylation after 17 to 18 hrs by cytoblot assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 8(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of HDAC8 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibition of HDAC6 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of HDAC6 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of HDAC6 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 8(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibition of HDAC8 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 3(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Inhibition of HDAC3 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 11(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of HDAC11 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 6(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of HDAC6 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 2(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of HDAC2 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 8(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 310nMAssay Description:Inhibition of HDAC8 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 1(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 310nMAssay Description:Inhibition of HDAC1 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 8(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 390nMAssay Description:Inhibition of HDAC8 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetPolyamine deacetylase HDAC10(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 430nMAssay Description:Inhibition of HDAC10 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 1(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 6.31E+3nMAssay Description:Inhibition of HDAC1 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 3(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 6.59E+3nMAssay Description:Inhibition of HDAC3 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 1(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 1.12E+4nMAssay Description:Inhibition of HDAC1 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 1(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 2.13E+4nMAssay Description:Inhibition of HDAC1 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 5(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 2.72E+4nMAssay Description:Inhibition of HDAC5 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 7(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 3.08E+4nMAssay Description:Inhibition of HDAC7 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 9(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 3.50E+4nMAssay Description:Inhibition of HDAC9 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 5(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 3.60E+4nMAssay Description:Inhibition of HDAC5 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 7(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 6.07E+4nMAssay Description:Inhibition of HDAC7 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 9(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 6.58E+4nMAssay Description:Inhibition of HDAC9 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 4(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 6.78E+4nMAssay Description:Inhibition of HDAC4 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetPolyamine deacetylase HDAC10(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 7.11E+4nMAssay Description:Inhibition of HDAC10 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 11(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 7.53E+4nMAssay Description:Inhibition of HDAC11 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 4(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 7.60E+4nMAssay Description:Inhibition of HDAC4 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 11(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of HDAC11 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetPolyamine deacetylase HDAC10(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of HDAC10 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 2(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of HDAC2 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 5(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of HDAC5 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 4(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of HDAC4 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 3(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of HDAC3 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 7(Human)
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Roche Pharmaceutical Research and Early Development
Curated by ChEMBL
Affinity DataIC50: 1.05E+5nMAssay Description:Inhibition of HDAC7 (unknown origin) using fluorogenic peptide as substrate by fluorescence assayMore data for this Ligand-Target Pair
